Importantly, silencing PAK4 by PAK4 and nicotinamide phosphoribosyl-transferase (NAMPT) dual inhibitor KPT–9274 reduces p-Bad, leading to the resensitization of Gem-drug-resistant PC cells. The gene discussed is NAMPT; the disease is pachyonychia congenita.